will compound pharmacies stop making tirzepatide Now that shortages of semaglutide and are resolved, you may wonder if compounded GLP-1s are going away. Here's why they haven't disappeared entirely. 🔗 Check GoodRx for savings at the link A Major GLP-1 Drug Shortage

doi:10.1056/NEJMra2412865 6Younossi ZM, Golabi P, de Avila L, et al

You should not take Mounjaro a day early if youre not planning to change your weekly dose day, as this means youll be taking Mounjaro more than once a week

About tirzepatide Tirzepatide is a once-weekly dual glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptor agonist that integrates the actions of both incretins into a single novel molecule

This peptide helps reduce inflammation and supports long-term joint health, without relying on NSAIDs or steroid injections

Ozempic is a once-weekly subcutaneous injectable medication and one of the GLP-1 medications prescribed by Calibrate clinicians

And without the continued downward trajectory that motivated continued use, exploring alternatives with different mechanisms becomes an appealing strategy to break through stalled progress